Related Experiment Video
Updated: Sep 25, 2026
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
[Significens of blood platelet CD62p in treating sudden deafness]
Qinna Zhang1, Liping Zhang, Lijun Xia
1Department of Otorhinolaryngology, First Hospital of Shanxi Medical University, Taiyuan 030001, China. cxbxx@public.ty.sx.cn
Objective:
To compare different treatment methods for sudden deafness of different blood platelet CD62p levels.
Methods:
Blood platelet was measured with flow cytometer. Patients with platelet CD62p over or less than 2% were treated with routine treatment (low molecular weight dextran, ATP, CoA and dexamethasone) or routine treatment plus batroxobin (thrombolysis) separately.
Results:
In the group with platelet CD62p > or = 2%, the effective rates of routine treatment was 60.5%, and that of routine treatment plus thrombolysis was 84.6%. There was significant difference between them. In the group with platelet CD62p < 2%, the effective rates of two methods were 65.0% and 71.8% respectively(no significant difference between them).
Conclusions:
Detecting CD62p in sudden deafness patients makes sense for deciding treatment project.
